Status of reduced glutathione in the human hepatoma cell line, HEP G2
- 1 September 1988
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 37 (17) , 3365-3368
- https://doi.org/10.1016/0006-2952(88)90653-3
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Mixed function oxidase and UDP-glucuronyltransferase activities in the human Hep G2 hepatoma cell lineBiochemical Pharmacology, 1988
- Drug metabolism by the human hepatoma cell, Hep G2Biochemical and Biophysical Research Communications, 1987
- Use of the human liver cell line Hep G2 in a modified Salmonella reversion assayCancer Letters, 1986
- Induction of drug metabolizing enzymes in human liver cell line Hep G2FEBS Letters, 1985
- Evaluation of a human hepatoma cell line as a target cell in genetic toxicologyMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1983
- Glutathione conjugation and DNA-binding of (±)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene and (±)-7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene in isolated rat hepatocytesCarcinogenesis: Integrative Cancer Research, 1982
- Metabolic activation of benzo[a]pyrene by a human hepatoma cell lineCarcinogenesis: Integrative Cancer Research, 1980
- The mechanism of bromobenzene-induced cytotoxicity studied with isolated hepatocytesArchives of Toxicology, 1980
- Enzyme-catalysed conjugations of glutathione with unsaturated compoundsBiochemical Journal, 1967
- A scheme for the colorimetric determination of microgram amounts of thiolsThe Analyst, 1958